# A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants

> **NCT06677996** · PHASE1 · COMPLETED · sponsor: **Immunome, Inc.** · enrollment: 22 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** varegacestat
- **DRUG:** Itraconazole (200 mg)

## Key facts

- **NCT ID:** NCT06677996
- **Lead sponsor:** Immunome, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-11
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-05-07
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2025-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06677996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06677996, "A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06677996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*